日本語 
Pharma
Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…
Fujirebio Acquires PSG to Boost Biological Material Supply
H.U. Group Holdings Inc., through its wholly owned subsidiary Fujirebio Holdings, Inc.…
NEC With Chugai Use AI to Speed Cancer Drug Predictions
NEC Corporation and Chugai Pharmaceutical Co., Ltd. worked together on an AI…
HekaBio And Alfresa Form Strategic Biopharma Partnership
HekaBio K.K. is a biopharma and MedTech platform in Japan. It has…
English